Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
49,485,704
-
Share change
-
-129,357
-
Total reported value
-
$12,052,989
-
Put/Call ratio
-
6.6%
-
Price per share
-
$0.24
-
Number of holders
-
45
-
Value change
-
-$1,007,880
-
Number of buys
-
15
-
Number of sells
-
28
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2022
As of 31 Dec 2022,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,485,704 shares.
The largest 10 holders included
Anson Funds Management LP, NEA Management Company, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Boxer Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, TLS Advisors LLC, BlackRock Inc., and CARLSON CAPITAL L P.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.